This review synthesizes rapid advances showing that programmable bacteria can target tumors, calm chronic inflammation, correct metabolic imbalances, and combat drug-resistant infections by acting as ...
CAMBRIDGE, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (SGTX), a biotechnology company that seeks to develop functional cures for acute and chronic diseases through its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results